Lowering costs to companies manufacturing and distributing new medical devices and drugs is one thing, but the cost to consumer is not something the FDA has control over. Any truly substantial change that would impact costs of drugs and medical devices in the United States would need to be proposed and approved by congress rather than the FDA itself and focus in on regulating insurance companies and pharmaceutical companies in their pricing choices.

Kindly add further points to the above mentioned sentence in support and give more detailed explanation